| Heartland Hhc And Hospice 1145 W Main Ave Suite 205, De Pere, WI, 54115 | |
| (920) 336-6455 |
News Archive
After a series of studies in the laboratory of Dr. Gregory Freund, a clearer picture is emerging: A disruption of signaling proteins in the immune system may be responsible for the inflammation that makes someone with type 2 diabetes feel sick and increases the risk of serious complications.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
Minnesota's Medicaid program faces more federal scrutiny on its rates. In the meantime, new Medicaid payment reforms are signed into law in Colorado.
Survival rates for the most premature babies at a top London hospital have more than doubled over a 20 year period, according to research published in the latest edition of the journal Acta Paediatrica.
› Verified 2 days ago
| Name | Heartland Hhc And Hospice |
|---|---|
| Location | 1145 W Main Ave Suite 205, De Pere, Wisconsin |
| Hospice ID | 521569 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
| SSA county code | 040 |
News Archive
After a series of studies in the laboratory of Dr. Gregory Freund, a clearer picture is emerging: A disruption of signaling proteins in the immune system may be responsible for the inflammation that makes someone with type 2 diabetes feel sick and increases the risk of serious complications.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
Minnesota's Medicaid program faces more federal scrutiny on its rates. In the meantime, new Medicaid payment reforms are signed into law in Colorado.
Survival rates for the most premature babies at a top London hospital have more than doubled over a 20 year period, according to research published in the latest edition of the journal Acta Paediatrica.
› Verified 2 days ago
| NPI Number | 1851336358 |
| Organization Name | Heartland Hospice Services Llc |
| Address | 1145 W Main Ave Ste 205 De Pere, Wisconsin, 54115 |
| Phone Number | (920)436-9380 |
News Archive
After a series of studies in the laboratory of Dr. Gregory Freund, a clearer picture is emerging: A disruption of signaling proteins in the immune system may be responsible for the inflammation that makes someone with type 2 diabetes feel sick and increases the risk of serious complications.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
Minnesota's Medicaid program faces more federal scrutiny on its rates. In the meantime, new Medicaid payment reforms are signed into law in Colorado.
Survival rates for the most premature babies at a top London hospital have more than doubled over a 20 year period, according to research published in the latest edition of the journal Acta Paediatrica.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.3 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 82.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.3 | 93.3 |
News Archive
After a series of studies in the laboratory of Dr. Gregory Freund, a clearer picture is emerging: A disruption of signaling proteins in the immune system may be responsible for the inflammation that makes someone with type 2 diabetes feel sick and increases the risk of serious complications.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
Minnesota's Medicaid program faces more federal scrutiny on its rates. In the meantime, new Medicaid payment reforms are signed into law in Colorado.
Survival rates for the most premature babies at a top London hospital have more than doubled over a 20 year period, according to research published in the latest edition of the journal Acta Paediatrica.
› Verified 2 days ago
| Home Health Aides | 20.5 |
| Counselors | 3 |
| Licensed Practical or Vocational Nurses | 3 |
| Medical Social Workers | 5.5 |
| Registered Nurses | 25 |
| Other Personnel | 38 |
| Total Employees | 95 |
|---|
News Archive
After a series of studies in the laboratory of Dr. Gregory Freund, a clearer picture is emerging: A disruption of signaling proteins in the immune system may be responsible for the inflammation that makes someone with type 2 diabetes feel sick and increases the risk of serious complications.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
Minnesota's Medicaid program faces more federal scrutiny on its rates. In the meantime, new Medicaid payment reforms are signed into law in Colorado.
Survival rates for the most premature babies at a top London hospital have more than doubled over a 20 year period, according to research published in the latest edition of the journal Acta Paediatrica.
› Verified 2 days ago
| Others | 110 |
| Total Volunteers | 110 |
|---|
News Archive
After a series of studies in the laboratory of Dr. Gregory Freund, a clearer picture is emerging: A disruption of signaling proteins in the immune system may be responsible for the inflammation that makes someone with type 2 diabetes feel sick and increases the risk of serious complications.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
Minnesota's Medicaid program faces more federal scrutiny on its rates. In the meantime, new Medicaid payment reforms are signed into law in Colorado.
Survival rates for the most premature babies at a top London hospital have more than doubled over a 20 year period, according to research published in the latest edition of the journal Acta Paediatrica.
› Verified 2 days ago
| Unity Hospice Location: 2366 Oak Ridge Circle, De Pere, Wisconsin, 54115 Phone: (920) 336-6455 |
| Heartland Hhc And Hospice Location: 1145 W Main Ave Suite 205, De Pere, Wisconsin, 54115 Phone: (920) 336-6455 |